NICE and NHS England announce plan to enable innovative tech to be adopted quicker
NHS patients in England will benefit from faster access to the most innovative and cutting-edge medical technologies under new plans announced today (23 May).
NHS patients in England will benefit from faster access to the most innovative and cutting-edge medical technologies under new plans announced today (23 May).
Five home-testing devices to diagnose a silent sleep condition harming the health of an estimated 2.5 million adults have been recommended by NICE in draft guidance.
More people with early breast cancer could be spared chemotherapy and therefore avoid the side effects associated with the treatment after tumour profiling tests were recommended by NICE.
Improved deal signals NICE recommendation of sickle cell treatment voxelotor.
As NICE celebrates its 25th anniversary, we look back on its journey from its humble beginnings in 1999. We explore NICE's role and the wide-ranging impact it has had on health and care. And we provide a summary of the organisational changes NICE is making to ensure it continues to add value to an evolving health and care system.
In this case study, we explore NICE International's collaboration with Ecuador and Peru. This partnership, supported by the UK Department of Business and Trade, focuses on the ongoing establishment of health technology evaluation.
This International Women’s Day, we’re focusing on the invaluable contributions of 2 of the women who help shape our guidance through their independent voluntary committee roles. They talk to us about their involvement with NICE and what #InspireInclusion means to them.
Melanie explains how the update to our quality standard on the transition from children’s to adults’ services will benefit young people, their families and carers.